InvestorsHub Logo
Followers 43
Posts 5405
Boards Moderated 0
Alias Born 03/05/2010

Re: None

Wednesday, 10/22/2014 10:48:17 PM

Wednesday, October 22, 2014 10:48:17 PM

Post# of 92948
Does this sound good to anyone? "Now, we have follow-up that extends to longer than 3 years in patients treated with hESC-derived stem cells, showing both safety and apparent efficacy." "The studies by Schwartz and colleagues 1 show that the use of stem cell lines is a viable strategy."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.